135 related articles for article (PubMed ID: 8838125)
1. Cystadenoma of spermatic cord resembling ovarian serous epithelial tumour of low malignant potential: immunohistochemical study suggesting Müllerian differentiation.
McCluggage WG; Shah V; Nott C; Clements B; Wilson B; Hill CM
Histopathology; 1996 Jan; 28(1):77-80. PubMed ID: 8838125
[TBL] [Abstract][Full Text] [Related]
2. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
Sun ZC
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
[TBL] [Abstract][Full Text] [Related]
3. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
Tong GX; Chiriboga L; Hamele-Bena D; Borczuk AC
Mod Pathol; 2007 Aug; 20(8):856-63. PubMed ID: 17529925
[TBL] [Abstract][Full Text] [Related]
4. Intratesticular serous cystadenoma of borderline malignancy. A pathological, histochemical and DNA content study of a case with long-term follow-up.
De Nictolis M; Tommasoni S; Fabris G; Prat J
Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):221-5. PubMed ID: 8236817
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors.
Klemi PJ; Takahashi S; Joensuu H; Kiilholma P; Narimatsu E; Mori M
Int J Gynecol Pathol; 1994 Jul; 13(3):228-33. PubMed ID: 7928055
[TBL] [Abstract][Full Text] [Related]
6. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.
Rutgers JL; Scully RE
Cancer; 1988 Jan; 61(2):340-8. PubMed ID: 3334969
[TBL] [Abstract][Full Text] [Related]
7. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations.
Remmele W; Kaiserling E; Zerban U; Hildebrand U; Bennek M; Jacobi-Nolde P; Pinkenburg FA
Hum Pathol; 1992 Jan; 23(1):75-9. PubMed ID: 1544675
[TBL] [Abstract][Full Text] [Related]
8. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis.
Rutgers JL; Scully RE
Cancer; 1988 Feb; 61(3):546-54. PubMed ID: 3338022
[TBL] [Abstract][Full Text] [Related]
9. Serous borderline tumor of the paratestis.
Maruyama H; Ohyama N; Hosokawa Y; Momose H; Yamada K; Tsutsumi M; Kuniyasu H; Enomoto Y; Uematsu K; Konishi Y
Pathol Int; 2008 May; 58(5):311-6. PubMed ID: 18429831
[TBL] [Abstract][Full Text] [Related]
10. Papillary serous carcinoma of ovarian type of the testis with borderline differentiation.
Guarch R; Rivas A; Puras A; Pesce C
Histopathology; 2005 May; 46(5):588-90. PubMed ID: 15842644
[No Abstract] [Full Text] [Related]
11. Paratesticular papillary serous cystadenocarcinoma--a case report.
Kurian RR; Prema NS; Belthazar A
Indian J Pathol Microbiol; 2006 Jan; 49(1):36-7. PubMed ID: 16625973
[TBL] [Abstract][Full Text] [Related]
12. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
13. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
Eltabbakh GH; Mount SL
J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
[TBL] [Abstract][Full Text] [Related]
14. Serous borderline tumor of the paratestis: a report of seven cases.
McClure RF; Keeney GL; Sebo TJ; Cheville JC
Am J Surg Pathol; 2001 Mar; 25(3):373-8. PubMed ID: 11224608
[TBL] [Abstract][Full Text] [Related]
15. Papillary serous cystadenoma of borderline malignancy arising in a parovarian paramesonephric cyst. Light microscopic and ultrastructural observations.
Chandraratnam E; Leong AS
Histopathology; 1983 Jul; 7(4):601-11. PubMed ID: 6885002
[TBL] [Abstract][Full Text] [Related]
16. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
18. Cystadenoma and cystadenocarcinoma with mesenchymal stroma of the liver. Immunohistochemical analysis.
Gourley WK; Kumar D; Bouton MS; Fish JC; Nealon W
Arch Pathol Lab Med; 1992 Oct; 116(10):1047-50. PubMed ID: 1384454
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
20. A Paratesticular Multicystic Tumor of the Tunica Vaginalis Testis as Rare Paratesticular Cystadenoma.
Draeger DL; Kraeft SK; Protzel C; Hakenberg OW
Urol Int; 2018; 101(2):245-248. PubMed ID: 28196363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
